BACKGROUND: The origin and the contribution of breast tumor heterogeneity to its progression are not clear. We investigated the effect of a growing orthotopic tumor formed by an aggressive estrogen receptor (ER)-negative breast cancer cell line on the metastatic potential of a less aggressive ER-positive breast cancer cell line for the elucidation of how the presence of heterogeneous cancer cells might affect each other's metastatic behavior. METHODS: ER positive ZR-75-1/GFP/puro cells, resistant to puromycin and non-tumorigenic/non-metastatic without exogenous estrogen supplementation, were injected intracardiacally into mice bearing growing orthotopic tumors, formed by ER negative MDA-MB-231/GFP/Neo cells resistant to G418. A variant cell...
Metastatic spread to the bone is the most common cause of mortality amongst breast cancer patients. ...
Breast cancer stem cells (CSCs) are thought to drive recurrence and metastasis. Their identity has b...
Breast cancer progression involves cancer cell heterogeneity, with generation of invasive/metastatic...
The origin and the contribution of breast tumor heterogeneity to its progression are not clear. We i...
Background: Progress in breast cancer (BC) research relies on the availability of suitable cell line...
We aimed to generate and characterize a novel cell line from a breast cancer bone metastasis to bett...
Breast cancer is one of the most common form of cancer among women globally and metastasis is the pr...
INTRODUCTION: Breast cancer grows, metastasizes and relapses from rare, therapy resistant cells with...
Background: Breast cancer cell lines are widely used tools to investigate breast cancer biology and ...
<div><p>Introduction</p><p>Breast cancer grows, metastasizes and relapses from rare, therapy resista...
Aim: Estrogen receptor α-positive (ER+) subtypes of breast cancer have the greatest predilection for...
The MCF-7 human breast cancer cell line and four derived variant sublines (R27, R3, R3–12, and R3–98...
Some hormone-independent breast cancers lack functional estrogen receptors (ERs) and show evidence o...
Triple negative breast cancer (TNBC) is a subtype that lacks expression of progesterone and estrogen...
Estrogen signaling plays a critical role in the pathogenesis of breast cancer. Because the majority ...
Metastatic spread to the bone is the most common cause of mortality amongst breast cancer patients. ...
Breast cancer stem cells (CSCs) are thought to drive recurrence and metastasis. Their identity has b...
Breast cancer progression involves cancer cell heterogeneity, with generation of invasive/metastatic...
The origin and the contribution of breast tumor heterogeneity to its progression are not clear. We i...
Background: Progress in breast cancer (BC) research relies on the availability of suitable cell line...
We aimed to generate and characterize a novel cell line from a breast cancer bone metastasis to bett...
Breast cancer is one of the most common form of cancer among women globally and metastasis is the pr...
INTRODUCTION: Breast cancer grows, metastasizes and relapses from rare, therapy resistant cells with...
Background: Breast cancer cell lines are widely used tools to investigate breast cancer biology and ...
<div><p>Introduction</p><p>Breast cancer grows, metastasizes and relapses from rare, therapy resista...
Aim: Estrogen receptor α-positive (ER+) subtypes of breast cancer have the greatest predilection for...
The MCF-7 human breast cancer cell line and four derived variant sublines (R27, R3, R3–12, and R3–98...
Some hormone-independent breast cancers lack functional estrogen receptors (ERs) and show evidence o...
Triple negative breast cancer (TNBC) is a subtype that lacks expression of progesterone and estrogen...
Estrogen signaling plays a critical role in the pathogenesis of breast cancer. Because the majority ...
Metastatic spread to the bone is the most common cause of mortality amongst breast cancer patients. ...
Breast cancer stem cells (CSCs) are thought to drive recurrence and metastasis. Their identity has b...
Breast cancer progression involves cancer cell heterogeneity, with generation of invasive/metastatic...